We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
Cap. Flow
+$2.97B
Cap. Flow %
6.1%
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$305M
2
CVS icon
CVS Health
CVS
+$190M
3
NVS icon
Novartis
NVS
+$175M
4
AVGO icon
Broadcom
AVGO
+$154M
5
WDC icon
Western Digital
WDC
+$144M

Sector Composition

Rank Sector Weight
1 Financials 24.38%
2 Healthcare 15.25%
3 Technology 13.09%
4 Industrials 10.62%
5 Energy 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPS
226
DELISTED
LENDER PROCESSING SERVICES INC
LPS
$32.8M 0.07%
877,975
+11,825
+1% +$409K
CNO icon
227
CNO Financial Group
CNO
$4.97B
$32.7M 0.07%
1,849,480
+62,480
+3% +$1M
FAF icon
228
First American
FAF
$7.67B
$32.1M 0.07%
1,138,476
-26,458
-2% -$687K
BCO icon
229
Brink's
BCO
$5.02B
$32M 0.07%
937,758
-129,809
-12% -$4.08M
BERY
230
DELISTED
Berry Global Group, Inc.
BERY
$31.9M 0.07%
1,462,102
+628,906
+75% +$12M
PTP
231
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
$31.3M 0.06%
511,292
-9,034
-2% -$554K
ABG icon
232
Asbury Automotive
ABG
$4.19B
$31.1M 0.06%
579,126
-43,055
-7% -$2.22M
ONIT
233
Onity Group
ONIT
$333M
$31.1M 0.06%
37,370
-10,214
-21% -$8.41M
PCG icon
234
PG&E
PCG
$47.8B
$30.9M 0.06%
767,581
+604,126
+370% +$24.8M
WSM icon
235
Williams-Sonoma
WSM
$26.7B
$30.4M 0.06%
1,042,248
-168,718
-14% -$4.72M
HUB.B
236
DELISTED
HUBBELL INC CL-B
HUB.B
$30.1M 0.06%
276,236
-128,229
-32% -$13.7M
MSCC
237
DELISTED
Microsemi Corp
MSCC
$29.7M 0.06%
1,190,305
-73,252
-6% -$1.78M
TEX icon
238
Terex
TEX
$7.98B
$29.6M 0.06%
705,283
-13,735
-2% -$498K
RAD
239
DELISTED
Rite Aid Corporation
RAD
$29.4M 0.06%
290,287
-9,945
-3% -$1.06M
ARAY icon
240
Accuray
ARAY
$28.4M
$29.2M 0.06%
3,353,100
-427,080
-11% -$3.31M
UVV icon
241
Universal Corp
UVV
$1.34B
$28.9M 0.06%
529,213
+3,486
+0.7% +$181K
MFA
242
MFA Financial
MFA
$929M
$28.5M 0.06%
1,008,563
-15,985
-2% -$468K
CPF icon
243
Central Pacific Financial
CPF
$997M
$28M 0.06%
1,396,700
+343,140
+33% +$6.46M
NSM
244
DELISTED
Nationstar Mortgage Holdings
NSM
$27.9M 0.06%
753,919
-11,160
-1% -$500K
AEGN
245
DELISTED
Aegion Corp
AEGN
$27.7M 0.06%
1,263,656
+413,911
+49% +$8.98M
CADE
246
DELISTED
Cadence Bank
CADE
$27.1M 0.06%
1,067,015
+44,360
+4% +$1.01M
SEM
247
DELISTED
Select Medical
SEM
$26.6M 0.05%
4,246,428
+167,684
+4% +$819K
SPLS
248
DELISTED
Staples Inc
SPLS
$26.4M 0.05%
1,663,693
-2,279,968
-58% -$35.5M
NNI icon
249
Nelnet
NNI
$4.79B
$26.2M 0.05%
622,713
+5,464
+0.9% +$230K
AAT
250
American Assets Trust
AAT
$1.49B
$25.6M 0.05%
814,140
+178,657
+28% +$5.72M

Similar funds

Boston Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.

  • Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
  • Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
  • Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
  • Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
  • Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
  • Boston Partners opened 71 new positions and closed 53 in Q4 2013.
  • Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.

Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.